Hippocrates Research (HR) is a Private Limited Company, as a company of Hippocrates Group qualified since 1995 as a CRO (Contract Research Organization). Our management has more than 20 years of experience in pharmaceutical world. It is supported by a complete training and professional updating program carried out at national and international level (training and refresher courses, problem solving, organization, communication). It includes medical expertise, pharmaceutical skills, Quality Assurance and regulatory, operational flexibility, aimed at achieving the objectives in order to reach the Customer satisfaction.
HR supports studies in Italy, from phase 1 (including first-in-human) to phase 4. Moreover, more than 40% of the HR total turnover is focused on NIS, including PASS and about 13% on medical devices and food supplements. Furthermore, HR has access to a broad and reliable domestic network of GPs, well trained in GCPs and suitable to carry out interventional (phase 3 and 4) and NIS studies.
HR has a recognized cutting-edge expertise for studies in Cardiology, Onco-haematology, Gastroenterology, Urology, Sexual Health and Dermatology. HR expertise is also recognised in Rare Diseases, Paediatrics and Ophthalmology.
FormaResults of many studies conducted by HR have been published in important scientific journals. In total, the results of about 60 projects where HR was involved, have been published in international scientific journals and 4 of them in the New England Journal of Medicine